VIVUS, Inc.
NASDAQ:VVUS
$12.82
$0.00
(0.00%)
Quote as of 1:15 PM EST on 02/09/12
|
$12.82
$0.00
(0.00%)
|
|
| Today's Open | $12.87 |
|---|---|
| Previous Close | $12.82 |
| Daily Range | $12.71 - $12.93 |
| 52-Week Range | $6.00 - $13.18 |
| Market Cap | $1.14B |
| P/E Ratio | -19.72 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 786,539 |
| Average Daily Volume | 1,861,691 |
| Current FY EPS | -$0.52 |
VVUS Information
| Description |
|---|
| A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Amgen, Vivus, Chelsea Therapeutics Prep for Key Catalysts in February
Biotech Investors Confident: Industry Sees Big VC Spending in 2011
Vivus' ED Drug Continues to Hold Up - Analyst Blog
Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals
Vivus' Obesity Drug Label Modified - Analyst Blog
Has Arena Pharmaceuticals Become the Perfect Stock?
US Stock Futures: HOT STOCKS TO WATCH
Don't Believe This Company's Warning
Arena Pharma Files Response to CRL - Analyst Blog
This Biotech's Obese To-Do List Is Done
